Quest Diagnostics Inc. (DGX)

102.60
NYSE : Health Services
Prev Close 100.85
Day Low/High 100.26 / 102.60
52 Wk Low/High 90.10 / 112.97
Avg Volume 1.07M
Exchange NYSE
Shares Outstanding 136.30M
Market Cap 13.89B
EPS 5.60
P/E Ratio 21.14
Div & Yield 2.00 (1.77%)

Latest News

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

Quest Diagnostics Becomes #71 Most Shorted S&P 500 Component, Replacing Concho Resources

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics To Acquire MedXM, Expanding Its Health Risk Assessment Services To Close Gaps In Care

Quest Diagnostics To Acquire MedXM, Expanding Its Health Risk Assessment Services To Close Gaps In Care

Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plans

Quest Diagnostics Completes Acquisition Of Shiel Medical Laboratory From Fresenius Medical Care

Quest Diagnostics Completes Acquisition Of Shiel Medical Laboratory From Fresenius Medical Care

Transaction broadens access to Quest's diagnostic innovations in the New York-New Jersey metropolitan area

Quest Diagnostics Completes Acquisition Of Cleveland HeartLab And Formalizes R&D Collaboration With Cleveland Clinic

Quest Diagnostics Completes Acquisition Of Cleveland HeartLab And Formalizes R&D Collaboration With Cleveland Clinic

Cleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart Disease

Quest Diagnostics To Present New Insights In Autoimmune Disease At The 2017 American College Of Rheumatology Meeting

Quest Diagnostics To Present New Insights In Autoimmune Disease At The 2017 American College Of Rheumatology Meeting

Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and Lupus

Quest Diagnostics Acquires California Laboratory Associates

Quest Diagnostics Acquires California Laboratory Associates

Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern California

'When I Think of October, I Think of Black Monday' -- Market Recon

'When I Think of October, I Think of Black Monday' -- Market Recon

We all knew that the Ugly Stick would be out on Monday, Oct. 17, 1987.

Quest Diagnostics To Acquire Cleveland HeartLab And Form Strategic Collaboration With Cleveland Clinic

Quest Diagnostics To Acquire Cleveland HeartLab And Form Strategic Collaboration With Cleveland Clinic

- Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease

Quest Diagnostics Completes Acquisition Of The Outreach Laboratory Services Of Two Hartford HealthCare Hospitals In Connecticut

Quest Diagnostics Completes Acquisition Of The Outreach Laboratory Services Of Two Hartford HealthCare Hospitals In Connecticut

Quest acquires service businesses of William W. Backus Hospital and The Hospital of Central Connecticut

Quest Diagnostics To Acquire Shiel Medical Laboratory From Fresenius Medical Care

Quest Diagnostics To Acquire Shiel Medical Laboratory From Fresenius Medical Care

Transaction to expand access to Quest's diagnostic innovations in the New York-New Jersey metropolitan area

One In Four Individuals Combine Opioids And Benzodiazepines, A Potentially Lethal Mix, According To Journal Of Addiction Medicine Study

One In Four Individuals Combine Opioids And Benzodiazepines, A Potentially Lethal Mix, According To Journal Of Addiction Medicine Study

Analysis of Quest Diagnostics prescription drug monitoring data also found that for more than half of results with concurrent use, one drug had been prescribed by a physician and one had not, suggesting potentially dangerous drug combinations without a physician's oversight

Quest Diagnostics Becomes #68 Most Shorted S&P 500 Component, Replacing CBOE Holdings

The most recent short interest data has been released for the 09/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics Moves To Convenient Nonfasting Cholesterol Testing With Improved Method For Assessing Heart Disease Risk And Aiding Treatment Decisions

Quest Diagnostics Moves To Convenient Nonfasting Cholesterol Testing With Improved Method For Assessing Heart Disease Risk And Aiding Treatment Decisions

Quest is first national diagnostic services provider to use novel LDL-cholesterol calculation that improves accuracy of heart disease screening and helps personalize treatment with lipid-lowering medications such as PCSK9 inhibitors and statins

Half Of Americans Tested Misuse Their Prescription Medications, According To Quest Diagnostics Analysis

Half Of Americans Tested Misuse Their Prescription Medications, According To Quest Diagnostics Analysis

New examination of 3.4 million drug monitoring lab results shows wide evidence of dangerous drug combinations, including opioids/benzodiazepines and heroin/fentanyl

Quest Diagnostics Becomes #84 Most Shorted S&P 500 Component, Replacing Zions Bancorporation

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: A- (Buy)